# Retracted Article: LncRNA OIP5-AS1 contributes to ox-LDL-induced inflammation and oxidative stress through regulating the miR-128-3p/CDKN2A axis in macrophages.

> **Reliability concern:** This paper was retracted on 2021-01-28. See notice: 10.1039/d1ra90042k.

- **DOI:** [10.1039/c9ra08322g](https://doi.org/10.1039/c9ra08322g)
- **Rating:** Limited (2.5 out of 5)
- **Verdict:** An incremental ceRNA-axis characterisation in ox-LDL-treated THP1 cells undermined by statistical errors and methods-section template contamination.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-05-30
- **Evaluation page:** https://www.nabu.science/paper/10.1039%2Fc9ra08322g

## Strengths

- **Coherent multi-step mechanistic validation chain** The study progresses logically from expression profiling through knockdown, bioinformatic prediction, dual-luciferase and RIP interaction validation, and rescue experiments, establishing a complete OIP5-AS1/miR-128-3p/CDKN2A regulatory axis.
  - Dimension: methodological rigour
  - Location: Results, Figs. 1–7
- **Multiple siRNA sequences confirm knockdown specificity** Three independent siRNA sequences targeting OIP5-AS1 were tested, with knockdown efficiency confirmed by qRT-PCR before selecting the most effective construct for downstream experiments.
  - Dimension: methodological rigour
  - Location: Fig. 2A
- **Dual interaction validation methods** The miR-128-3p interaction with OIP5-AS1 is confirmed by both dual-luciferase reporter assay and RNA immunoprecipitation, providing independent lines of evidence for the proposed binding.
  - Dimension: contribution
  - Location: Figs. 3B–C

## Limitations

- **Methods describe constructs never used in experiments** The Plasmid and Transfection section describes cloning MALAT1 and TRIM65 overexpression vectors into pcDNA3.1, yet neither gene appears anywhere in the Results or Discussion. This methods–results mismatch is consistent with template contamination or manuscript assembly error and raises concerns about manuscript preparation quality.
  - Dimension: methodological rigour
  - Location: Methods, Plasmid and Transfection
- **Inappropriate statistical analysis for multi-group comparisons** Student's t-test is applied throughout, including for dose-response experiments (4 concentrations) and rescue experiments (4 conditions), without ANOVA or multiple comparison correction. This inflates Type I error rates across the numerous endpoints tested.
  - Dimension: methodological rigour
  - Location: Statistical Analysis; Figs. 2–7
- **Therapeutic claims exceed single-cell-line evidence** The paper claims to provide 'a theoretical basis for the treatment of AS' based entirely on THP1 cell line experiments without animal models, primary macrophages, or patient data. No differentiation of THP1 monocytes into macrophages is reported, yet the work is framed as macrophage biology.
  - Dimension: contribution
  - Location: Abstract; Conclusion; Methods, Cell Culture

## Reliability checks

Concerns (4 of 4 checks).

- **Internal coherence:** Noted. The Methods section describes cloning MALAT1 and TRIM65 overexpression vectors that are never used in any reported experiment, indicating template contamination or manuscript preparation error. The core experimental chain (OIP5-AS1/miR-128-3p/CDKN2A) is internally consistent across abstract, results, and conclusions, but translational claims in the abstract and conclusion substantially exceed the single-cell-line in vitro evidence.
- **Research conduct:** Noted. No ethics approval, conflicts of interest, or data availability statements are provided. For a 2020 cell-line-only study this is not automatically a red flag but represents a gap in reporting standards.
- **Reference integrity:** Clean. All 36 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Concern
- **Summary:** This paper was retracted on 2021-01-28. See notice: 10.1039/d1ra90042k.
- **Last checked:** 2026-10-17
